Lemonade Stock: Growth Is Working, But The Insurance Economics Still Are Not (NYSE:LMND)
· seekingalpha.com
Lemonade's lower reinsurance cessions materially improved net expense absorption, but operating expenses still increased. Learn why LMND stock is a sell.
This is a $5-$10 stock. It is a $400M net premium company writing unprofitable lines, burning its reinsurers, and consuming cash like Pacman. It does not have
...